These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27096315)

  • 1. Getting the Skinny on CD4(+) T Cell Survival in Fatty Livers.
    Walker CM; Lemon SM
    Immunity; 2016 Apr; 44(4):725-7. PubMed ID: 27096315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.
    Ma C; Kesarwala AH; Eggert T; Medina-Echeverz J; Kleiner DE; Jin P; Stroncek DF; Terabe M; Kapoor V; ElGindi M; Han M; Thornton AM; Zhang H; Egger M; Luo J; Felsher DW; McVicar DW; Weber A; Heikenwalder M; Greten TF
    Nature; 2016 Mar; 531(7593):253-7. PubMed ID: 26934227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non alcoholic-fatty liver disease causes selective CD4
    L'Hermitte A; Pham S; Cadoux M; Couty JP
    Med Sci (Paris); 2016 Nov; 32(11):1023-1026. PubMed ID: 28008846
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes.
    Ma C; Zhang Q; Greten TF
    FEBS J; 2018 Feb; 285(4):752-762. PubMed ID: 28857485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype and function of CXCR5+CD45RA-CD4+ T cells were altered in HBV-related hepatocellular carcinoma and elevated serum CXCL13 predicted better prognosis.
    Duan Z; Gao J; Zhang L; Liang H; Huang X; Xu Q; Zhang Y; Shen T; Lu F
    Oncotarget; 2015 Dec; 6(42):44239-53. PubMed ID: 26517519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut-derived lymphocyte recruitment to liver and induce liver injury in non-alcoholic fatty liver disease mouse model.
    Hu Y; Zhang H; Li J; Cong X; Chen Y; He G; Chi Y; Liu Y
    J Gastroenterol Hepatol; 2016 Mar; 31(3):676-84. PubMed ID: 26430807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells.
    Kuang DM; Peng C; Zhao Q; Wu Y; Chen MS; Zheng L
    Hepatology; 2010 Jan; 51(1):154-64. PubMed ID: 19902483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
    Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
    J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice.
    Rolla S; Alchera E; Imarisio C; Bardina V; Valente G; Cappello P; Mombello C; Follenzi A; Novelli F; Carini R
    Clin Sci (Lond); 2016 Feb; 130(3):193-203. PubMed ID: 26558403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma.
    Tomimaru Y; Mishra S; Safran H; Charpentier KP; Martin W; De Groot AS; Gregory SH; Wands JR
    Vaccine; 2015 Mar; 33(10):1256-66. PubMed ID: 25629522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ T Cell Loss Drives NAFLD Progression to Hepatocellular Carcinoma.
    Cancer Discov; 2016 May; 6(5):OF8. PubMed ID: 26988666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model.
    Morales-Kastresana A; Sanmamed MF; Rodriguez I; Palazon A; Martinez-Forero I; Labiano S; Hervas-Stubbs S; Sangro B; Ochoa C; Rouzaut A; Azpilikueta A; Bolaños E; Jure-Kunkel M; Gütgemann I; Melero I
    Clin Cancer Res; 2013 Nov; 19(22):6151-62. PubMed ID: 24030703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice.
    Yokohama K; Fukunishi S; Ii M; Nakamura K; Ohama H; Tsuchimoto Y; Asai A; Tsuda Y; Higuchi K
    Int J Mol Med; 2016 Nov; 38(5):1499-1506. PubMed ID: 28025996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunology of hepatocellular carcinoma.
    Paroli M; Perrone A; Bonavita MS; Barnaba V
    Ital J Gastroenterol; 1991 Nov; 23(8):494-7. PubMed ID: 1661196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play.
    Charrez B; Qiao L; Hebbard L
    World J Gastroenterol; 2016 Feb; 22(8):2494-502. PubMed ID: 26937137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
    Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
    Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of epidural block combined with general anesthesia on antitumor characteristics of T helper cells in hepatocellular carcinoma patients.
    Wang XT; Lv M; Guo HY
    J Biol Regul Homeost Agents; 2016; 30(1):67-77. PubMed ID: 27049077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [THE EFFECTIVENESS OF THE MODERN IMMUNOACTIVE PREPARATION IMMUNOFAN FOR MEDICAL REHABILITATION OF PATIENTS WITH NONALCOHOLIC STEATOHEPATITISIS AGAINST NEUROCIRCULATORY DYSTONIA, AFTER INFECTIOUS MONONUCLEOSIS].
    Yugan YL; Sotskaya YA; Chabarova AB
    Lik Sprava; 2015; (5-6):132-9. PubMed ID: 27089731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged survival of human hepatocarcinoma cells in the liver of newborn C57BL/6 mice and resulting cellular xenorejection, especially the activation of hepatic natural killer T cells.
    Du X; Bai Z; Zhang J; Liu L; Han Y; Wang Z; Huan T; Wu B
    Pathobiology; 2010; 77(3):115-28. PubMed ID: 20516727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.
    Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E
    BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.